VentriPoint Ev To Sales vs Free Cash Flow Yield Analysis

VPT Stock

CAD 0.10 0.01 9.09%

VentriPoint Diagnostics financial indicator trend analysis is much more than just breaking down VentriPoint Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VentriPoint Diagnostics is a good investment. Please check the relationship between VentriPoint Diagnostics Ev To Sales and its Free Cash Flow Yield accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ev To Sales vs Free Cash Flow Yield

Ev To Sales vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VentriPoint Diagnostics Ev To Sales account and Free Cash Flow Yield. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between VentriPoint Diagnostics' Ev To Sales and Free Cash Flow Yield is 0.54. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of VentriPoint Diagnostics, assuming nothing else is changed. The correlation between historical values of VentriPoint Diagnostics' Ev To Sales and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of VentriPoint Diagnostics are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ev To Sales i.e., VentriPoint Diagnostics' Ev To Sales and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from VentriPoint Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, VentriPoint Diagnostics' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 47.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.7 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	48.8K	50.9K	66.7K	45.9K
Income Tax Expense	92.9K	136.1K	3.0	2.85

Depreciation And Amortization Income Tax Expense

VentriPoint Diagnostics fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Investments	Non Current Liabilities Total	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Intangible Assets	Short Long Term Debt Total	Other Current Liab	Short Term Debt	Other Assets	Net Tangible Assets	Long Term Debt	Other Current Assets
Total Assets		-0.31	0.93	-0.97	-0.39	0.2	1.0	1.0	0.47	0.56	0.36	-0.32	1.0	0.01	-0.16	0.22	0.19	0.38	0.26	-0.48	-0.29	-0.49	0.29	-0.13	-0.48	-0.23
Total Current Liabilities	-0.31		-0.62	0.45	0.15	0.24	-0.34	-0.34	-0.09	-0.44	0.25	0.93	-0.31	0.1	0.31	-0.39	-0.4	-0.41	-0.28	0.54	0.62	0.42	0.11	-0.32	0.01	0.27
Total Stockholder Equity	0.93	-0.62		-0.97	-0.39	0.04	0.93	0.93	0.41	0.63	0.15	-0.65	0.93	-0.08	-0.38	0.31	0.27	0.46	0.33	-0.67	-0.42	-0.53	0.19	0.08	-0.45	-0.21
Net Debt	-0.97	0.45	-0.97		0.39	-0.11	-0.97	-0.97	-0.37	-0.58	-0.2	0.5	-0.97	0.01	0.37	-0.2	-0.17	-0.43	-0.34	0.62	0.29	0.51	-0.27	-0.06	0.46	0.16
Retained Earnings	-0.39	0.15	-0.39	0.39		-0.69	-0.36	-0.36	-0.66	-0.88	-0.21	0.13	-0.37	0.51	0.03	-0.53	-0.38	-0.89	-0.77	0.56	0.6	0.82	-0.54	0.2	0.75	0.07
Accounts Payable	0.2	0.24	0.04	-0.11	-0.69		0.17	0.17	0.37	0.4	0.37	0.3	0.19	-0.05	0.28	0.07	-0.01	0.54	0.55	-0.14	-0.52	-0.54	0.59	-0.44	-0.52	-0.04
Cash	1.0	-0.34	0.93	-0.97	-0.36	0.17		1.0	0.41	0.54	0.3	-0.35	1.0	0.04	-0.18	0.18	0.14	0.37	0.25	-0.49	-0.29	-0.48	0.26	-0.09	-0.44	-0.24
Cash And Short Term Investments	1.0	-0.34	0.93	-0.97	-0.36	0.17	1.0		0.41	0.54	0.3	-0.35	1.0	0.03	-0.18	0.18	0.15	0.37	0.25	-0.49	-0.29	-0.48	0.26	-0.09	-0.44	-0.24
Net Receivables	0.47	-0.09	0.41	-0.37	-0.66	0.37	0.41	0.41		0.78	0.6	-0.02	0.45	-0.51	0.14	0.73	0.62	0.53	0.3	-0.38	-0.34	-0.56	0.35	-0.5	-0.7	-0.17
Common Stock Shares Outstanding	0.56	-0.44	0.63	-0.58	-0.88	0.4	0.54	0.54	0.78		0.27	-0.38	0.55	-0.63	-0.07	0.75	0.58	0.89	0.64	-0.67	-0.59	-0.87	0.4	-0.22	-0.71	-0.21
Other Stockholder Equity	0.36	0.25	0.15	-0.2	-0.21	0.37	0.3	0.3	0.6	0.27		0.35	0.34	-0.12	0.38	0.33	0.33	0.07	-0.07	0.05	-0.04	-0.25	0.53	-0.44	-0.36	-0.25
Total Liab	-0.32	0.93	-0.65	0.5	0.13	0.3	-0.35	-0.35	-0.02	-0.38	0.35		-0.32	0.08	0.63	-0.27	-0.3	-0.35	-0.32	0.68	0.47	0.31	0.11	-0.49	0.1	0.06
Total Current Assets	1.0	-0.31	0.93	-0.97	-0.37	0.19	1.0	1.0	0.45	0.55	0.34	-0.32		0.02	-0.17	0.2	0.16	0.36	0.25	-0.48	-0.28	-0.47	0.28	-0.13	-0.47	-0.23
Short Term Investments	0.01	0.1	-0.08	0.01	0.51	-0.05	0.04	0.03	-0.51	-0.63	-0.12	0.08	0.02		0.02	-0.61	-0.29	-0.5	-0.12	0.45	0.14	0.45	-0.03	0.1	0.47	0.14
Non Current Liabilities Total	-0.16	0.31	-0.38	0.37	0.03	0.28	-0.18	-0.18	0.14	-0.07	0.38	0.63	-0.17	0.02		0.13	0.07	-0.04	-0.23	0.64	-0.11	-0.08	0.04	-0.6	0.25	-0.43
Property Plant And Equipment Net	0.22	-0.39	0.31	-0.2	-0.53	0.07	0.18	0.18	0.73	0.75	0.33	-0.27	0.2	-0.61	0.13		0.91	0.58	0.27	-0.41	-0.35	-0.61	0.21	-0.2	-0.43	-0.21
Non Current Assets Total	0.19	-0.4	0.27	-0.17	-0.38	-0.01	0.14	0.15	0.62	0.58	0.33	-0.3	0.16	-0.29	0.07	0.91		0.42	0.3	-0.3	-0.27	-0.45	0.25	-0.12	-0.3	-0.11
Non Currrent Assets Other	0.38	-0.41	0.46	-0.43	-0.89	0.54	0.37	0.37	0.53	0.89	0.07	-0.35	0.36	-0.5	-0.04	0.58	0.42		0.83	-0.6	-0.65	-0.9	0.56	-0.08	-0.47	-0.14
Intangible Assets	0.26	-0.28	0.33	-0.34	-0.77	0.55	0.25	0.25	0.3	0.64	-0.07	-0.32	0.25	-0.12	-0.23	0.27	0.3	0.83		-0.5	-0.51	-0.7	0.65	0.01	-0.37	0.21
Short Long Term Debt Total	-0.48	0.54	-0.67	0.62	0.56	-0.14	-0.49	-0.49	-0.38	-0.67	0.05	0.68	-0.48	0.45	0.64	-0.41	-0.3	-0.6	-0.5		0.37	0.63	-0.22	-0.27	0.59	-0.12
Other Current Liab	-0.29	0.62	-0.42	0.29	0.6	-0.52	-0.29	-0.29	-0.34	-0.59	-0.04	0.47	-0.28	0.14	-0.11	-0.35	-0.27	-0.65	-0.51	0.37		0.63	-0.23	0.1	0.33	0.26
Short Term Debt	-0.49	0.42	-0.53	0.51	0.82	-0.54	-0.48	-0.48	-0.56	-0.87	-0.25	0.31	-0.47	0.45	-0.08	-0.61	-0.45	-0.9	-0.7	0.63	0.63		-0.52	0.14	0.5	0.19
Other Assets	0.29	0.11	0.19	-0.27	-0.54	0.59	0.26	0.26	0.35	0.4	0.53	0.11	0.28	-0.03	0.04	0.21	0.25	0.56	0.65	-0.22	-0.23	-0.52		-0.01	-0.21	0.15
Net Tangible Assets	-0.13	-0.32	0.08	-0.06	0.2	-0.44	-0.09	-0.09	-0.5	-0.22	-0.44	-0.49	-0.13	0.1	-0.6	-0.2	-0.12	-0.08	0.01	-0.27	0.1	0.14	-0.01		0.32	0.14
Long Term Debt	-0.48	0.01	-0.45	0.46	0.75	-0.52	-0.44	-0.44	-0.7	-0.71	-0.36	0.1	-0.47	0.47	0.25	-0.43	-0.3	-0.47	-0.37	0.59	0.33	0.5	-0.21	0.32		-0.01
Other Current Assets	-0.23	0.27	-0.21	0.16	0.07	-0.04	-0.24	-0.24	-0.17	-0.21	-0.25	0.06	-0.23	0.14	-0.43	-0.21	-0.11	-0.14	0.21	-0.12	0.26	0.19	0.15	0.14	-0.01

Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	314.3K	801.6K	9.5M	6.0M	1.9M	2.0M
Total Current Liabilities	1.9M	1.8M	1.1M	1.1M	1.4M	2.1M
Total Stockholder Equity	(2.5M)	(2.3M)	8.3M	4.6M	189.7K	199.2K
Net Debt	1.1M	843.8K	(9.1M)	(4.7M)	(1.0M)	(969.0K)
Retained Earnings	(37.9M)	(39.9M)	(43.7M)	(48.6M)	(53.5M)	(50.8M)
Accounts Payable	1.2M	1.0M	988.6K	842.0K	856.2K	792.2K
Cash	13.8K	526.0K	9.3M	5.2M	1.3M	1.5M
Cash And Short Term Investments	13.8K	526.0K	9.3M	5.2M	1.3M	1.5M
Net Receivables	67.7K	165.3K	197.5K	374.2K	285.5K	299.8K
Common Stock Shares Outstanding	63.4M	74.5M	136.1M	156.0M	156.8M	164.7M
Liabilities And Stockholders Equity	314.3K	801.6K	9.5M	6.0M	1.9M	2.0M
Other Stockholder Equity	6.0M	6.4M	9.8M	10.4M	10.9M	7.5M
Total Liab	2.8M	3.2M	1.2M	1.4M	1.7M	2.6M
Total Current Assets	176.0K	714.5K	9.5M	5.7M	1.6M	1.9M
Non Current Liabilities Total	868.0K	1.3M	125.4K	367.4K	297.0K	468.6K
Property Plant And Equipment Net	138.3K	87.1K	42.5K	313.3K	246.6K	258.9K
Non Current Assets Total	138.3K	87.1K	42.5K	313.3K	246.6K	134.6K
Other Current Liab	12.8K	500.0	62.3K	122.1K	453.6K	753.2K
Short Term Debt	257.1K	42.8K	34.6K	91.6K	55.0K	52.3K
Net Tangible Assets	(1.7M)	(1.0M)	(2.5M)	(2.3M)	(2.1M)	(2.2M)
Other Current Assets	63.8K	23.1K	35.9K	103.5K	56.9K	73.8K
Common Stock	29.5M	31.0M	42.2M	42.7M	49.1M	28.8M
Property Plant Equipment	49.9K	49.0K	138.3K	87.1K	100.1K	71.6K
Net Invested Capital	(1.5M)	(1.1M)	8.5M	4.7M	327.8K	311.4K
Net Working Capital	(1.7M)	(1.1M)	8.4M	4.6M	240.1K	228.1K
Capital Stock	29.5M	31.0M	42.2M	42.7M	49.1M	39.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC